Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
1998 1
1999 3
2000 3
2001 3
2002 2
2003 1
2004 4
2005 5
2006 6
2007 1
2008 6
2009 8
2010 11
2011 11
2012 11
2013 18
2014 26
2015 29
2016 45
2017 33
2018 30
2019 25
2020 29
2021 36
2022 26
2023 14

Text availability

Article attribute

Article type

Publication date

Search Results

335 results

Results by year

Filters applied: . Clear all
Page 1
Biomarkers for the diagnosis and management of heart failure.
Castiglione V, Aimo A, Vergaro G, Saccaro L, Passino C, Emdin M. Castiglione V, et al. Heart Fail Rev. 2022 Mar;27(2):625-643. doi: 10.1007/s10741-021-10105-w. Epub 2021 Apr 14. Heart Fail Rev. 2022. PMID: 33852110 Free PMC article. Review.
Other biomarkers evaluated as predictors of adverse outcome are galectin-3, growth differentiation factor 15, mid-regional pro-adrenomedullin, and makers of renal dysfunction. ...
Other biomarkers evaluated as predictors of adverse outcome are galectin-3, growth differentiation factor 15, mid-regional pro …
Current and future pharmacological therapies for NAFLD/NASH.
Sumida Y, Yoneda M. Sumida Y, et al. J Gastroenterol. 2018 Mar;53(3):362-376. doi: 10.1007/s00535-017-1415-1. Epub 2017 Dec 16. J Gastroenterol. 2018. PMID: 29247356 Free PMC article. Review.
GLP-1RA and SGLT2 inhibitors, which are currently approved for use in diabetes, have shown early efficacy in NASH, and also have beneficial cardiovascular or renal effects. Innovative NASH therapies include four main pathways. ...Antifibrotic agents are a cysteine-cysteine …
GLP-1RA and SGLT2 inhibitors, which are currently approved for use in diabetes, have shown early efficacy in NASH, and also have beneficial …
Twist1 regulates macrophage plasticity to promote renal fibrosis through galectin-3.
Wu Q, Sun S, Wei L, Liu M, Liu H, Liu T, Zhou Y, Jia Q, Wang D, Yang Z, Duan M, Yang X, Gao P, Ning X. Wu Q, et al. Cell Mol Life Sci. 2022 Feb 19;79(3):137. doi: 10.1007/s00018-022-04137-0. Cell Mol Life Sci. 2022. PMID: 35182235 Free PMC article.
Ablation of Twist1 in macrophages markedly alleviated renal tubular injury and renal fibrosis in UUO mice, accompanied by a lower extent of macrophage infiltration and M2 polarization in the kidney. ...Up-regulation of galectin-3 recovered Twist …
Ablation of Twist1 in macrophages markedly alleviated renal tubular injury and renal fibrosis in UUO mice, accompanied by a lo …
Galectin-3 Activation and Inhibition in Heart Failure and Cardiovascular Disease: An Update.
Suthahar N, Meijers WC, Silljé HHW, Ho JE, Liu FT, de Boer RA. Suthahar N, et al. Theranostics. 2018 Jan 1;8(3):593-609. doi: 10.7150/thno.22196. eCollection 2018. Theranostics. 2018. PMID: 29344292 Free PMC article. Review.
Galectin-3 is a versatile protein orchestrating several physiological and pathophysiological processes in the human body. In the last decade, considerable interest in galectin-3 has emerged because of its potential role as a biotarget. ...
Galectin-3 is a versatile protein orchestrating several physiological and pathophysiological processes in the human body. In t …
Therapeutic Targets for Heart Failure Identified Using Proteomics and Mendelian Randomization.
Henry A, Gordillo-Marañón M, Finan C, Schmidt AF, Ferreira JP, Karra R, Sundström J, Lind L, Ärnlöv J, Zannad F, Mälarstig A, Hingorani AD, Lumbers RT; HERMES and SCALLOP Consortia. Henry A, et al. Circulation. 2022 Apr 19;145(16):1205-1217. doi: 10.1161/CIRCULATIONAHA.121.056663. Epub 2022 Mar 18. Circulation. 2022. PMID: 35300523 Free PMC article.
Among these, 8 proteins had evidence of a causal association with HF that was robust to multiverse sensitivity analysis: higher CSF-1 (macrophage colony-stimulating factor 1), Gal-3 (galectin-3) and KIM-1 (kidney injury molecule 1) were positively asso …
Among these, 8 proteins had evidence of a causal association with HF that was robust to multiverse sensitivity analysis: higher CSF-1 (macro …
Mesenchymal stem cells ameliorate renal fibrosis by galectin-3/Akt/GSK3β/Snail signaling pathway in adenine-induced nephropathy rat.
Tang H, Zhang P, Zeng L, Zhao Y, Xie L, Chen B. Tang H, et al. Stem Cell Res Ther. 2021 Jul 16;12(1):409. doi: 10.1186/s13287-021-02429-z. Stem Cell Res Ther. 2021. PMID: 34271976 Free PMC article.
CONCLUSION: The mechanism of MSCs anti-renal fibrosis was probably mediated by galectin-3/Akt/GSK3beta/Snail signaling pathway. Galectin-3 may be a valuable target for treating renal fibrosis....
CONCLUSION: The mechanism of MSCs anti-renal fibrosis was probably mediated by galectin-3/Akt/GSK3beta/Snail signaling …
Cardiac biomarkers of heart failure in chronic kidney disease.
Han X, Zhang S, Chen Z, Adhikari BK, Zhang Y, Zhang J, Sun J, Wang Y. Han X, et al. Clin Chim Acta. 2020 Nov;510:298-310. doi: 10.1016/j.cca.2020.07.040. Epub 2020 Jul 23. Clin Chim Acta. 2020. PMID: 32710942 Review.
Heart failure remains a continuing threat to patients with chronic kidney disease (CKD). Although various heart failure biomarkers have been applied for early detection, diagnosis and prognosis in CKD, these are easily affected by renal insufficiency thus limiting u …
Heart failure remains a continuing threat to patients with chronic kidney disease (CKD). Although various heart failure biomarkers ha …
Novel Biomarkers of Heart Failure.
Savic-Radojevic A, Pljesa-Ercegovac M, Matic M, Simic D, Radovanovic S, Simic T. Savic-Radojevic A, et al. Adv Clin Chem. 2017;79:93-152. doi: 10.1016/bs.acc.2016.09.002. Epub 2016 Nov 3. Adv Clin Chem. 2017. PMID: 28212715 Review.
In this review, seven groups of biomarkers associated to myocardial stretch (mid-regional proatrial natriuretic peptide, MR-proANP), myocyte injury (high-sensitive troponins, hs-cTn; heart-type fatty acid-binding protein, H-FABP; glutathione transferase P1, GSTP1), matrix remodel …
In this review, seven groups of biomarkers associated to myocardial stretch (mid-regional proatrial natriuretic peptide, MR-proANP), myocyte …
Urinary Galectin-3 as a Novel Biomarker for the Prediction of Renal Fibrosis and Kidney Disease Progression.
Ou SM, Tsai MT, Chen HY, Li FA, Lee KH, Tseng WC, Chang FP, Lin YP, Yang RB, Tarng DC. Ou SM, et al. Biomedicines. 2022 Mar 2;10(3):585. doi: 10.3390/biomedicines10030585. Biomedicines. 2022. PMID: 35327386 Free PMC article.
Plasma galectin-3 (Gal-3) is associated with organ fibrosis, but whether urinary Gal-3 is a potential biomarker of kidney disease progression has never been explored. ...The urinary Gal-3 level may be useful for the identification of pati …
Plasma galectin-3 (Gal-3) is associated with organ fibrosis, but whether urinary Gal-3 is a potential biomarker …
Galectin-3 in Renal Pathology: More Than Just an Innocent Bystander.
Desmedt V, Desmedt S, Delanghe JR, Speeckaert R, Speeckaert MM. Desmedt V, et al. Am J Nephrol. 2016;43(5):305-17. doi: 10.1159/000446376. Epub 2016 May 12. Am J Nephrol. 2016. PMID: 27166158 Free article. Review.
Finally, the therapeutic potential of anti-galectin-3 inhibitors is discussed. KEY MESSAGES: Due to its multifunctional character, galectin-3 plays a pivotal role in interstitial fibrosis and progression of chronic kidney disease. Inhibition of …
Finally, the therapeutic potential of anti-galectin-3 inhibitors is discussed. KEY MESSAGES: Due to its multifunctional charac …
335 results